product containing precisely brompheniramine maleate 400 microgram/1 milliliter and codeine phosphate 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution
product containing levetiracetam in parenteral dose form